Bliss GVS Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
272.00
4.05 (1.51%)
BSENSE

May 07

BSE+NSE Vol: 10.67 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "272.00",
    "chg": 4.05,
    "chgp": "1.51%",
    "dir": 1,
    "prev_price": "267.95",
    "mcapval": "2,880.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE416D01022",
    "curr_date": "May 07",
    "curr_time": "",
    "bse_nse_vol": "10.67 lacs",
    "exc_status": "Active",
    "traded_date": "May 07, 2026",
    "traded_date_str": "2026 05 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Bliss GVS Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bliss-gvs-pharma-ltd-3978477",
        "imagepath": "",
        "date": "2026-05-06 23:16:16",
        "description": "The next results date for Bliss GVS Pharma Ltd is scheduled for 12 May 2026...."
      },
      {
        "title": "Bliss GVS Pharma Gains 5.20%: Key Milestones and Market Dynamics This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-520-key-milestones-and-market-dynamics-this-week-3971677",
        "imagepath": "",
        "date": "2026-05-02 16:01:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> Stock opens strong at Rs.273.70 (+4.23%)</p>\n                    <p><strong>28 Apr:</strong> New 52-week high and all-time high reached (Rs.280.2 / Rs.278.2)</p>\n                    <p><strong>29 Apr:</strong> Minor consolidation with slight declines</p>\n                    <p><strong>30 Apr:</strong> Strong rebound closes week at Rs.276.25 (+3.17%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.262.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.276.25</div><d..."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3972206",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BlissGVSPharmaL_mojoScore_3972206.png",
        "date": "2026-05-01 10:10:04",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 280.2",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs2802-3966119",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BlissGVSPharmaL_priceRelatedfactors_3966119.png",
        "date": "2026-04-28 09:44:40",
        "description": "With a remarkable 122.33% gain over the past year, Bliss GVS Pharma Ltd surged to a fresh 52-week high of Rs 280.2 on 28 Apr 2026, outpacing the Sensex which declined by 3.62% during the same period. This milestone caps a sustained rally fuelled by strong technical momentum and a series of bullish signals across multiple timeframes."
      },
      {
        "title": "Bliss GVS Pharma Ltd Hits All-Time High of Rs 278.2 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-at-rs2782-3966062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BlissGVSPharmaL_priceRelatedfactors_3966062.png",
        "date": "2026-04-28 09:32:23",
        "description": ""
      },
      {
        "title": "Bliss GVS Pharma Gains 1.65%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-165-4-key-factors-driving-the-weeks-momentum-3962617",
        "imagepath": "",
        "date": "2026-04-25 16:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Stock opens at Rs.253.40, down 1.92% amid flat Sensex</p>\n                    <p><strong>22 Apr:</strong> New 52-week high at Rs.272.95 and all-time high at Rs.271.65</p>\n                    <p><strong>23 Apr:</strong> Further 52-week and all-time highs at Rs.277.7 and Rs.277.45</p>\n                    <p><strong>24 Apr:</strong> Week closes at Rs.262.60, down 2.36% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.253.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"s..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 277.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs2777-3958914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BlissGVSPharmaL_priceRelatedfactors_3958914.png",
        "date": "2026-04-23 10:11:36",
        "description": "With a remarkable 120.83% gain over the past year, Bliss GVS Pharma Ltd surged to a fresh 52-week high of Rs 277.7 on 23 Apr 2026, showcasing a sustained momentum that outpaces the broader Sensex, which declined by 2.58% over the same period."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Ltd Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-on-23-april-2026-3958747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BlissGVSPharmaL_priceRelatedfactors_3958747.png",
        "date": "2026-04-23 09:55:55",
        "description": ""
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 272.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs27295-3956877",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BlissGVSPharmaL_priceRelatedfactors_3956877.png",
        "date": "2026-04-22 09:44:06",
        "description": "From a 52-week low of Rs 105.05 to a new peak of Rs 272.95, Bliss GVS Pharma Ltd has more than doubled in value over the past year, delivering a remarkable 119.3% return. This surge comes amid a backdrop of mixed market conditions, with the Sensex down 0.73% today but up nearly 7% over the last three weeks, highlighting the stock’s standout momentum in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 334,
    "sid": "730684",
    "stock_news_url": "https://www.marketsmojo.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the second quarter and half year ended September 30, 2019 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshkati a Regional Daily, on November 13, 2019.",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Monday, November 11, 2019 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019 published in The Economic Times an English Daily and Maharashtra Times a Regional Daily, on November 05, 2019.",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Updates",
      "datetime": "05-Nov-2019"
    },
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding a press release dated October 07, 2019, titled \"we enclose herewith Press Release announcing that Kremoint Pharma Private Limited, India, a 70% subsidiary of Bliss GVS Pharma Limited (BGPL) has received a compliant certification from the U.S. Food and Drug Administration (FDA) that was based on the inspection conducted at the Company s facility located at M.I.D.C, Ambernath (East), Thane-District.\".",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Press Release",
      "datetime": "09-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>50%</strong> dividend, ex-date: 18 Feb 26",
          "dt": "2026-02-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Bliss GVS Pharma Gains 5.20%: Key Milestones and Market Dynamics This Week

2026-05-02 16:01:32

Key Events This Week

27 Apr: Stock opens strong at Rs.273.70 (+4.23%)

28 Apr: New 52-week high and all-time high reached (Rs.280.2 / Rs.278.2)

29 Apr: Minor consolidation with slight declines

30 Apr: Strong rebound closes week at Rs.276.25 (+3.17%)

stock-recommendationAnnouncement

Bliss GVS Pharma Limited - Updates

13-Nov-2019 | Source : NSE

Bliss GVS Pharma Limited has informed the Exchange regarding 'Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the second quarter and half year ended September 30, 2019 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshkati a Regional Daily, on November 13, 2019.

Bliss GVS Pharma Limited - Updates

05-Nov-2019 | Source : NSE

Bliss GVS Pharma Limited has informed the Exchange regarding 'Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Monday, November 11, 2019 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019 published in The Economic Times an English Daily and Maharashtra Times a Regional Daily, on November 05, 2019.

Bliss GVS Pharma Limited - Press Release

09-Oct-2019 | Source : NSE

Bliss GVS Pharma Limited has informed the Exchange regarding a press release dated October 07, 2019, titled "we enclose herewith Press Release announcing that Kremoint Pharma Private Limited, India, a 70% subsidiary of Bliss GVS Pharma Limited (BGPL) has received a compliant certification from the U.S. Food and Drug Administration (FDA) that was based on the inspection conducted at the Company s facility located at M.I.D.C, Ambernath (East), Thane-District.".

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

12 May 2026

stock-summary
DIVIDEND

Bliss GVS Pharma Ltd has declared 50% dividend, ex-date: 18 Feb 26

stock-summary
SPLITS

Bliss GVS Pharma Ltd has announced 1:10 stock split, ex-date: 11 Mar 08

stock-summary
BONUS

Bliss GVS Pharma Ltd has announced 3:5 bonus issue, ex-date: 26 Sep 08

stock-summary
RIGHTS

No Rights history available